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CHAPTER ONE
OVERVIEW AND HYPOTHESES
Misfolded, toxic forms of the amyloid protein, alpha synuclein (α-syn), have been
implicated in Parkinson’s disease (PD) pathology and have been shown to spread
throughout the brain in a prion-like manner, explaining the characteristic, progressive loss
of dopaminergic neurons in PD1–3. A major barrier to identifying targets for more impactful
treatment of PD is the lack of mechanistic understanding behind this process of α-syn
propagation. Mechanisms currently being investigated include those behind cellular
release, uptake, and intracellular processing of α-syn aggregates4. Evidence suggests that
exogenous α-syn aggregates can enter recipient cells through the endocytic pathway to
subsequently induce endocytic vesicle rupture, resulting in the cytosolic deposition of
exogenous α-syn aggregates5–7. More specifically, previous colocalization studies in our
lab provide evidence that α-syn induced vesicle rupture, labeled by recruitment of
overexpressed mCherry-Galectin 3 (chGal3) to exposed beta-galactoside sugars located
exclusively at the site of rupture, occurs mainly at the lysosomal stage of the endocytic
pathway7.
Moving forward, we have aimed to corroborate this previous evidence of α-syn
induced lysosomal rupture, and to investigate the cellular repercussions of this rupture with
respect to cell death and α-syn transfer. We hypothesized that α-syn aggregates can
compromise the function of lysosomes, leading to the release of lysosomal contents,
including key hydrolytic enzymes, into the cytosol. To test this, we have
immunofluorescently labeled one of the most abundant lysosomal proteolytic enzymes,
cathepsin B, to analyze the level of lysosomal protease dispersion upon treatment with α-
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syn aggregates in aim 1. Further, we hypothesized that ruptured lysosomes would be
incapable of resealing after α-syn induced rupture. We have tested this hypothesis in aim
2 using a triple colocalization analysis between live cell lysosomal markers, labeled α-syn
aggregates, and chGal3 labeled rupture events. Last, we hypothesized that membraneproximal, endocytic lysosomes and autolysosomes may undergo calcium-dependent
lysosomal exocytosis to release their α-syn contents prior to rupture. In aim 3, we have
investigated this mechanism of α-syn release by inducing calcium influx while imaging
membrane proximal lysosomes and their contents through TIRF-M.

CHAPTER TWO
REVIEW OF LITERATURE
PD Pathology, Symptoms, and Treatments
The aberrant accumulation of α-syn amyloid structures within the brain is
increasingly acknowledged as the underlying cause of PD. As α-syn continues to aggregate,
inclusions are formed within CNS cell bodies or axons that are referred to as Lewy bodies
(LBs) or Lewy neurites (LNs) respectively, and are the common histopathological feature
of all synucleinopathies including PD, DLB, and MSA8–13. Advancing α-syn pathology
leads to the progressive loss of neuronal and glial cell populations through unconfirmed
mechanisms, giving rise to the distinct neurological symptoms of each synucleopathy14,15.
Although the involvement of α-syn inclusions is a universal feature of these
synucleinopathies, each disease within this category is characterized differently and tends
to involve distinct brain regions, cell types, symptoms, and time courses for disease
progression. MSA is one of the most distinct synucleinopathies in that it is diagnosed after
discovery of extensive Lewy body structures within glial tissue, and is characterized by
massive glial scarring in autonomic centers of the brain, giving rise to many symptoms
including dysphagia and severe respiratory dysfunction13,16,17. Alternatively, PD is
characterized by the death of dopaminergic neurons within the Substantia Nigra pars
compacta (SNpc) of the midbrain, yet Lewy body and Lewy neurite structures can be found
throughout the CNS18. Further, the intricacies of α-syn pathology in PD patients can vary
significantly as different brain regions are affected, giving rise not only to the cardinal signs
of bradykinesia, resting tremor, rigidity, and impaired postural instability, but also an array
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of secondary symptoms including loss of olfaction and cognitive deficits19,20. The eventual
spread of pathology throughout cortical areas may explain the high instances of dementia
known as PDD, which affects approximately 26% of PD patients at initial diagnosis, and
78% at 8 years after diagnosis21. The characteristics of PDD are similar to those of DLB,
where cortical areas are the most drastically affected by neuronal death, yet the amyloid
deposits of α-syn in DLB are much more prevalent and develop throughout the CNS much
more quickly than those found in patients with PD/PDD22. This may explain why, from the
time of diagnosis, the average life expectancy in DLB is just 5 years compared to the 9
year life expectancy after onset of PD23.
Current treatments for PD and all synucleinopathies revolve around temporary
symptom management and do not prevent disease progression through neuronal loss. The
standard of care for PD includes treatment with L-DOPA, a precursor that can cross the
BBB and be converted into dopamine by DOPA decarboxylase, thereby enhancing
neurotransmission from dopaminergic SNpc neurons to the dorsal striatum24. After
pharmacological treatments begin to fail and produce complications like worsening
dyskinesia, qualifying PD patients can undergo surgical implantation of an electrode
stimulator, normally into the subthalamic nucleus, to inhibit abnormal neural activity
associated with motor dysfunction25. Although deep brain stimulation (DBS) drastically
improves motor symptoms and life expectancy, eventually, even DBS treatment fails to
alleviate movement associated symptoms25. More importantly, these treatments have
limited effect on the non-motor symptoms of PD (cognitive impairment, speech deficits,
pain, imbalance, etc.), and, for that reason, is currently only indicated as a treatment for
motor symptoms26. Additional treatments that may become publically available in the near
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future include grafting of stem cells to replace dying SNpc dopaminergic neurons, although
this approach also does not address the underlying pathology27.
Origin of Pathology
It has been well established that dopaminergic neurons within the SNpc undergo
selective, accelerated loss in PD, but the explanation for this phenomenon is still largely
debated. Despite the selective damage to SNpc neurons, aberrant α-syn aggregation is
commonly thought to originate in other areas of the CNS or possibly the periphery, such
as the dorsal motor nucleus, glossopharyngeal nerve, vagal nerve, the anterior olfactory
nucleus, or even the enteric nervous system within the GI tract14,28. Those who accept the
Braak hypothesis believe that α-syn pathology spreads in a predictable manner throughout
the CNS, entering the brain through the brainstem from peripheral origination sites 14.
However, the previously mentioned wide spectrum of symptoms associated with PD
suggests that spreading pathology may be unique in many cases and therefore difficult to
predict. Various additional patterns of spreading pathology have also been recorded,
including the observation that LNs are initially larger and more prevalent than LBs.14
Properties of Alpha Synuclein
Synuclein proteins are expressed systemically under normal conditions, but they
are most abundant within the CNS where they can comprise as much as 1% of the total
cytosolic protein content29. Within the cytosol, α-syn is localized to the synaptic termini
and the nuclear envelope, explaining the origin of the name ‘synuclein’30,31. In its free
cytosolic form, α-syn is soluble, monomeric, and unfolded with no secondary structure,
although contact with lipid membranes will cause α-syn to adopt an amphipathic alpha
helical structure, most likely through hydrophobic interactions32. This dichotomy of α-syn
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structure has led to investigation into the potential role of α-syn in vesicle trafficking; a
line of thinking that has thus far proved to be accurate. Most notably, a recent study from
Burré et al suggests that α-syn forms multimers of the helical structure while in contact
with vesicle membranes, and is essential to the formation of SNARE complex proteins33.
Alternatively, in states of synucleopathy, α-syn misfolds to form amyloid,
filamentous structures containing phosphorylated α-syn beta-sheets34–36. Once amyloid
structures form, they are strongly resistant to degradation by proteinases37. Perplexingly,
initial misfolding seems to have little genetic influence since the WT form of α-syn is
involved in 80% of PD cases, which are considered sporadic, while genetic variations
(SNPs, duplications, and triplications) are known to promote early onset PD in the other
20% of cases. It has been proposed that particular point mutations may promote formation
of LBs and LNs by destabilizing the functional helical structure of α-syn, thereby
increasing the probability of the protein adopting an amyloid structure32. Studies
investigating duplications and triplications of the SNCA gene, on the other hand, have
shown that simply overexpressing α-syn will promote development of amyloid
pathology38,39. Beyond these fairly rare genetic variations in the SNCA gene, age is the
greatest known risk factor for PD, as is the case for so many neurodegenerative diseases.
Exogenous Alpha Synuclein Uptake and Vesicle Rupture
Pathological forms of α-syn have been detected extracellularly (e.g. CSF, plasma)
in individuals with PD, evidence of α-syn translocation from the cytosol40–42. As these
extracellular α-syn aggregates come into contact with the external leaflet of recipient cell
plasma membranes, they are known to induce endocytosis, although the specific
mechanism of endocytosis remains unknown43. This mechanism of cellular entry is very
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similar to that of other pathogens, namely adenovirus. In order to fully progress through
the viral life cycle after endocytosis, adenovirus must escape the endocytic pathway prior
to degradation within lysosomes. Studies performed by Dr. Chris Wiethoff at Loyola
suggest that adenovirus effectively evades degradation by inducing endocytic vesicle
rupture to gain access to the cytosol. Vesicular rupture events in this and other recent
studies were measured through the overexpression of a fusion protein, mCherry-Galectin
3 (chGal3)44,45. Cells were transduced to stably overexpress chGal3 based on the affinity
of the Galectin 3 carbohydrate recognition domain for beta-galactoside sugars present
exclusively on the extracellular surface, and the topologically equivalent interior leaflet of
endocytic vesicle membranes46 (Figure #1-i). When vesicle rupture occurs, these sugars
become exposed to the cytosol where chGal3 is diffusely localized, allowing chGal3 to be
recruited to form punctuates which can be measured above background fluorescence as
individual rupture events (Figure #1-ii).

(i)

(ii)

Figure 1. Schematic of the chGal3 labeled rupture system. Overexpressed Cherry-Galectin 3 (chGal3) is
diffusely localized under normal conditions. After vesicle rupture occurs, chGal3 binds exposed sugars to
form punctuates. (i) Illustrated depiction of chGal3 re-localization. (ii) Fluorescent images of two different
neuronal cell types depicting chGal3 re-localization as a result of treatment with α-syn aggregates.
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Further studies from the Wiethoff lab using this chGal3 assay system suggest that
induction of vesicle rupture, in the context of adenovirus, is dependent on adenoviral
protein VI47. Protein VI is thought to induce this membrane rupture by exerting a
biomechanical tension on the membrane, achieved through interaction between the curved
N-terminal, amphipathic α-helical structure of the protein and the vesicle membrane47. This
induced rupture event in the context of adenovirus has been shown to occur more
frequently at early stages along the endocytic pathway, particularly at the stage of the early
endosomes44. Using the same assay system for vesicle rupture, we have been able to begin
characterizing similar rupture events induced by α-syn.
Just like the adenovirus, α-syn adopts an N-terminal amphipathic α-helical structure
in association with lipid membranes48–50. Yet, misfolded α-syn does not seem to exhibit the
same evolutionarily driven, early escape from the endocytic pathway. Instead, our studies
suggest that α-syn is likely to progress along the endocytic pathway until the inhabited
vesicle matures to become an acidified lysosome, containing active proteases7. Alpha
synuclein has been shown to induce rupture preferentially at this lysosomal stage of
endocytosis7. Moreover, our studies show that α-syn aggregates can progress through the
endocytic pathway to induce lysosomal rupture within a 24 hour time period7. This would
not only explain the ability of α-syn to form Lewy body structures in the cytosol of recipient
cells, but also may explain the ability of α-syn aggregates to induce cell death since
lysosomal rupture will trigger the release of active proteases which are capable of
activating pro-apoptotic pathways. Through the quantification of active caspase-3,
apoptotic activation as a result of vesicle rupture in models of PD has become a major area
of investigation7,51,52.

9

Cathepsin Dispersion Following Lysosomal Rupture
The link between endocytic vesicle rupture and caspase-3 related cell death is likely
to involve dispersion of hydrolytic enzymes from the lysosomal compartment (Figure #2).
Of the many hydrolytic enzymes contained within the lysosomal lumen, the aspartic and
cysteine cathepsins, cathepsin D and cathepsin B respectively, are known to be most
abundant within lysosomes and have also been implicated in the activation of various cell
death pathways upon aberrant release into the cytosol53–56.

Cyt-C
Figure 2. Model of α-syn induced cell death
through lysosomal rupture and cathepsin release.

Cathepsin D is responsible for activating many of the cysteine cathepsins in the
acidic environment of the lysosomal lumen, but cathepsin B undergoes autocatalytic
activation through the cleavage of its own N-terminal propeptide under lysosomal
conditions57. The subsequent release of active cathepsin B under pathological conditions is
particularly threatening to intracellular environment due to the unique ability of cathepsin
B to remain significantly active at neutral pH, especially when bound to naturally occurring
heparin58,59. Once released, cathepsin B has not only been shown to necrotically degrade
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tissue, but also to activate apoptotic pathways through the cleavage of Bid, a Bcl-2 family
protein, to form the active ligand, tBid52,53,57,58. After tBid is produced, it can initiate
downstream activation of the apoptisome. This is accomplished by tBid after allosteric
activation of Bak, subsequent Bak/Bax oligomerization, and release of Cyt-C through the
Bak/Bax channel on the outer mitochondrial membrane53. The same oligomerization and
outcome can also be induced in the opposite manner when cathepsin D is released to
activate Bax54. Following oligomerization of Bax and Bak, reactive oxygen species are
released from the mitochondria, ultimately leading to phosphorylation of α-syn at Ser-129
and subsequent enhancement of α-syn aggregation to form Lewy body structures, although
the specific kinases involved have yet to be identified34,60,61. This sequence of cellular
events could explain the currently undescribed pathway of cell death in PD, and could shed
light on potential mechanisms of α-syn propagation. For these reasons, the localizations of
both cathepsin D and cathepsin B within models of PD have become a key interest.
Multiple studies provide compelling evidence that both lysosomal and
mitochondrial dysfunctions are associated with PD pathology53,60,62–64. We believe that
cathepsin dispersion due to α-syn induced lysosomal rupture could explain both of these
implicated types of dysfunction. However, the cellular repercussions of cathepsin release
can be variable depending on the extent to which cathepsin release occurs55. Lysosomes
that become moderately permeabilized over time to release small amounts of active
cathepsins may selectively induce apoptosis through Bax/Bak activation, while full rupture
of lysosomes to release high concentrations of cathepsins can result in unregulated
necrosis55. If necrosis is induced in PD, damage would not only occur within the cell of
pathological origin, but a loss of cell membrane integrity could feasibly enhance the
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propagation of PD pathology by allowing additional release of α-syn aggregates for uptake
by neighboring cells. Determining the role of aberrant cathepsin release in the progression
of PD will be instrumental in the identification of degenerative pathways, mechanisms of
intercellular propagation, and eventual therapeutic targets.
Seeding of endogenous alpha synuclein
In addition to cathepsin dispersion, exogenous α-syn aggregates can likely be
released into the cytosol after rupture of the endocytic vesicle. This vesicular escape could
allow exogenous aggregates to contribute to the formation of LB structures within the
cytosol by serving as nucleation points not only for other exogenous α-syn aggregates, but
for endogenous α-syn that has yet to misfold65. This occurrence has been described by
multiple groups, including Brundin et al, who conducted studies demonstrating that
endogenously overexpressed human α-syn can transfer from donor to recipient cells in a
time dependent manner in vitro, and to grafted dopaminergic neurons in animal models to
seed further formation of LBs and LNs3,65,66. More importantly, this type of transfer has
been shown to induce measurable decreases in both viability and striatal fiber density of
grafted neurons67,68.
Alpha Synuclein Release
The Brundin lab is one of many that have contributed to the extensive repertoire
of studies supporting the prion hypothesis of α-synuclein propagation. Additional studies
from the Seung-Jae Lee lab at Konkuk University have provided evidence of in vitro
transfer that is enhanced by inhibition of autophagy, while the Kordower lab at Rush
University has reported transfer upon post-mortem analysis of clinically grafted
neurons27,69. Although all of these studies provide fantastic evidence that α-syn transfer
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can occur, very little progress has been made toward understanding the underlying
mechanisms of α-syn release. Perhaps the only major mechanistic finding to date is that
standard secretory mechanisms of α-syn release can be ruled out due to persisting release
after inhibition of secretory vesicle formation by treatment with BFA70. This lack of
knowledge makes mechanistic study of α-syn release an extremely important, yet
demanding and unsupported area of study. In order to make progress, pilot studies must
be performed to investigate feasible alternatives.
Role of Intracellular Calcium in Alpha Synuclein Transfer
The process of calcium-dependent exocytosis is extremely well studied and
normally involves interactions between intracellular vesicles and the inner leaflet of the
plasma membrane through SNARE protein complex formation71. Secretory and synaptic
vesicles are guided to target destinations by specific membrane bound Rab GTPases which
interact with cytoskeletal-associated motor proteins to facilitate transport72. Upon arrival
at the target site, vesicular SNARE protein interacts with t-SNARE on the inner leaflet of
the plasma membrane, followed by formation of the full SNARE complex. Once the
SNARE complex is formed, vesicles are docked and primed, awaiting calcium influx and
binding to synaptotagmin calcium sensor proteins as the final signal to initiate fusion and
release of vesicle contents into the extracellular space.
More recently, it has been established that membrane proximal lysosomes are
capable of undergoing exocytosis through the same mechanism. In fact, there is evidence
to suggest that lysosomes are the predominant intracellular vesicle species to undergo
calcium dependent exocytosis in non-secretory cells, and that all cells utilize lysosomal
exocytosis for a variety of functions, including membrane repair and cell response to
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invading pathogens73–76. In lysosomes, exocytosis is facilitated by the calcium sensor,
synaptotagmin VII, and is has been associated with the release of lysosomal contents into
the extracellular space58,73,75,77,78. Since lysosomes often contain α-syn aggregates79, the
tendency for lysosomes to undergo exocytosis in response to calcium influx implicates
lysosomal exocytosis as a potential release mechanism for α-syn aggregates.
Misfolded forms of α-syn can be directed into the lumen of lysosomes through
either the endocytic pathway, if the aggregates are exogenous in origin, or through the
autophagy-lysosome pathway (ALP) as the cell attempts to sequester and degrade
increasing levels of aberrant, endogenous aggregates from the cytosol under pathological
conditions80. Further, α-syn aggregates are known to cause dysfunction within the ALP,
the consequences of which are enhanced α-syn accumulation within lysosomes and
increased release of α-syn aggregates from cells69,80. This increased release of α-syn
aggregates caused by ALP dysfunction has proven to cause cellular consequences, as it has
been directly linked to increased apoptosis in neighboring cells through the measurement
of caspase-3 activation69.
If α-syn is known to accumulate in lysosomes, and cannot be released through
standard secretory mechanisms, perhaps lysosomal exocytosis is a feasible mechanism of
propagation. Recent thought-provoking studies have successfully demonstrated a calciumdependent release of uncharacterized exosomes containing α-syn, presumably being
released from cells through the fusion of MVBs with the plasma membrane. Nonetheless,
somewhat contrasting studies provide evidence to suggest that free aggregates of α-syn are
also often released into the extracellular space69,81. A possible explanation for this
collection of findings is the proposed model on page #41, in which lysosomal exocytosis
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can explain the calcium-dependent release of both vesicular and free α-syn aggregates
depending on the trafficking of α-syn through the endocytic and autophagy-lysosome
pathways (Figure #16).
Using TIRF microscopy, we aimed to determine whether calcium dependent
lysosomal exocytosis may play a role in α-syn release and propagation. Calcium influx was
induced by treatment with various ionophores, namely calcium ionophores A23187 and
calcium ionomycin73,81. We hypothesized that calcium influx would induce lysosomal
migration and fusion to the PM, resulting in a corresponding increase in visible α-syn
release from neuronal cell lines in vitro.
Significance of this Study
The significance of our overall study is that it aims to identify novel therapeutic
targets related to the propagation of pathology in not only PD, but many related
synucleinopathies. If our findings contribute to an improved understanding of α-syn
toxicity, intracellular trafficking, and release, then the direction of current research may
pivot from symptom management approaches to propagation prevention with the potential
of entirely halting disease progression in relevant synucleinopathies.

CHAPTER THREE
MATERIALS & METHODS
Cell culture
The SH-SY5Y human neuroblastoma cell line was acquired from the American
Type Culture Collection (ATCC). Cells were cultured in Dulbecco's modified Eagle's
Medium (DMEM) containing phenol red (Invitrogen) and supplemented with 10% fetal
bovine serum (FBS), 10 ug/ml ciprofloxacin hydrochloride, 1,000 U/ml penicillin, and
1,000 U/ml streptomycin. For live cell imaging, DMEM lacking phenol red was used, and
cells were both cultured and imaged in live cell microscopy Delta T Dishes (Bioptechs).
Overexpression of cherry-galectin 3
For vesicle rupture experiments, SH-SY5Y cells were transduced to stably
overexpress chGal3 using a lentiviral viral vector (pLVX) containing the chGal3 gene
under control of a CMV promoter. To generate lentivirus for transduction, HEK 293T cells
were transfected using PEI as a transfection reagent with a mixture of equivalent parts
VSVg, ΔNRF, and pLVX-CMV-chGal3 plasmid. Lentiviral particles were purified 24
hours post-transfection from conditioned media of 293T cells using a 0.45um Millipore
syringe. SH-SY5Y cells were then cultured to 80% confluency, treated with the purified
lentivirus, and spinoculated at 13°C for 2h at 1200 x g. The resulting SH-SY5Y chGal3
cells were selected using 5 ug/ml puromycin within the previously mentioned culture
medium.
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Alpha synuclein aggregation and labeling
Full length, recombinant α-syn aggregates for these experiments were generated by
constant 3-day agitation of purified α-syn monomer in PBS, at a concentration of 5 mg/ml
and a constant temperature of 37°C82. To prepare aggregates for fluorescence microscopy,
they were labeled with DyLight™ 488 NHS-ester fluorophores (ThermoFisher).
Oligomeric structure of aggregated α-syn was confirmed by EM, and was verified to have
increased molecular weight compared to α-syn monomer by SDS- and native-PAGE. Cells
in all studies were treated with α-syn aggregates for 24 hours, although concentrations were
different for specific experiments, varying within the recommended 1ug/ml to 5ug/ml
range of concentrations normally used for treatment with exogenous aggregates82.
Immunofluorescent Staining
For cathepsin B dispersion experiments, cells were fixed in 0.1 M PIPES
with 3.7% formaldehyde (Polysciences) at a pH of 6.8 for 20 minutes. Immediately after
fixation, cells were incubated with one of two polyclonal, rabbit anti-cathepsin B
antibodies (Abcam at 1ug/ml, or Santa Cruz at 0.5ug/ml), in a PBS solution containing
10% NDS, 0.1% Saponin, (Sigma-Aldrich) and 0.01% NaN3 for 1.5 hours. After primary
staining, samples were fluorescently labeled with anti-Rabbit 576-conjugated secondary
antibody at a concentration of 1:500, and DAPI (1ug/ml) for 20 minutes. Additional
staining of vesicular antigens in control experiments was done under the same IF protocol
using 1:400 mouse anti-EEA1 (BD Biosciences) and 1:400 mouse anti-LAMP-2 (BD
Biosciences) followed by incubation with 1:500 488-conjugated anti-mouse secondary
antibody (BD Biosciences).
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Drug-induced vesicle rupture
As a positive control for lysosomal rupture and cathepsin B dispersion, cells were
treated with 10mM LLOMe in DMEM for 1 hour, followed by replacement of drug
containing media with standard media for a post-treatment incubation period of two hours
before fixation. Cells were then fixed and stained for cathepsin B according to the above
immunofluorescence protocol.
Wide-field fluorescence deconvolution microscopy
Immunofluorescence imaging was performed on a DeltaVision microscope
(Applied Precision) fitted with a 12-bit CoolSNAP HQ digital camera (Photometrics) and
1.4-numerical aperture 100X objective lens.
Live-cell fluorescence images were generated for triple colocalization analysis
with the same DeltaVision microscope and 100X objective lens, fitted with an alternate
16-bit Cascade 2 EMCCD digital camera (Photometrics). During imaging, cells were
maintained within a Weather StationTM chamber at 5% CO2 and 37°C.
Resulting images in each study were deconvolved immediately after acquisition
using the SoftWoRx deconvolution software (Applied Precision).
Analysis of deconvolved images
The analysis of resulting, deconvolved three-dimensional images was carried out
within the Imaris software package (Bitplane). Surfaces were generated for channels of
interest, and applied to all collected images using the high-throughput Batch Coordinator
tool (Bitplane). Multiple parameters from the Batch output were considered, including
both maximum fluorescence intensity and volume of generated surfaces for
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colocalization analysis, or overall surface count for the quantification of fluorescent
puncta abundance between treatment groups for the cathepsin B dispersion study.
Total internal reflection microscopy
To visualize calcium-dependent exocytosis of α-syn aggregates at the membrane of
human neuronal cells, SH-SY5Y cells were plated onto Fibronectin (Sigma-Aldrich)
coated 8-well, 1.0 Borosilicate chamber slides (ThermoFisher) and imaged using live cell,
total internal reflection fluorescence microscopy. A Nikon TIRF microscope equipped with
an EMCCD iXon 887 camera, computer-controlled automatic filter wheels (Sutter), 1.49
NA x 100 TIRF-optimized objective, and objective heating element. Labeled α-syn
aggregates were excited by a 445 nm Argon laser passed through a 488-reflecting dichroic
mirror optimized for TIRF (Semrock). For most experiments, the stream acquisition
function of the Metamorph software package was used to take TIRF images focused on the
bottom membrane of plated cells every 238 ms for an average duration of 180 seconds. In
select experiments, filter automation was used to image chGal3 and 488-labeled α-syn in
alternating 0.5 second intervals for an average duration of 180 seconds. Single
epifluorescent images of the 488-labeled α-syn were taken before and after stream
acquisition in all experiments. Before and after stream acquisition, chGal3 was excited by
a Prior Lumen 200 broad spectrum laser, and selectively imaged using a dichroic filter set
specific to 574nm wavelength emission (Semrock).
Calcium Influx
During stream acquisition, calcium ionophores Ionomycin and A23187 were used
to induce calcium influx in vitro. Plated cells were cultured within 200ul of media just
before imaging by TIRF-M. During imaging, either 200ul of .5uM Ionomycin was added
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to yield a .25uM treatment, or 200ul of 5uM A23187 to yield a 2.5uM treatment. Starting
concentrations for each of these ionophores were determined by review of literature73,81,
and were further optimized by titrations to reach ideal effect while maintaining cell
viability.

CHAPTER FOUR
ALPHA SYNUCLEIN INDUCES CATHEPSIN B DISPERSION
INTRODUCTION
Lysosomal dysfunction has been implicated as the physiological mechanism
behind numerous diseases and is known to negatively impact mitochondrial function in
addition to other essential functions of the cell, leading to cell damage and loss83,84.
Further, the majority of diseases related to lysosomal dysfunction are a direct result of
deficiencies in enzymes within the lysosomal lumen, resulting in toxicity and cell death. 84
Previous findings support the notion that synucleinopathies may lead to the same lysosomal
enzyme deficiencies through induced lysosomal membrane damage7. If this is the case,
aberrant forms of α-syn may induce the release of active proteases into the cytosol, a
process that could be a direct mechanistic explanation of α-syn toxicity. A strong tool for
the verification of this process in this study has been be the use of known lysosomal
disruptor, LLOMe, which has been shown to induce cathepsin-dependent cell death as a
well characterized parallel to α-syn induced lysosomal rupture and cell death85.
Previous studies have indicated potential cellular repercussions of vesicle rupture
and subsequent release of active cathepsins, but there is currently no direct evidence of
cathepsin release in models of PD. We aim to confirm this occurrence in order to
corroborate our previous findings of lysosomal rupture induced by α-syn, and also to
further implicate the tBid apoptosis pathway in PD pathology. We hypothesize that samples
treated with α-syn will have significantly increased lysosomal vesicle rupture events,
measured by both increased galectin 3 puncta and dissipation of signal from IF labeled
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lysosomal proteases (Figure #3). Therefore, we expect to measure decreased Cathepsin B
puncta in samples treated with α-syn aggregates compared to untreated samples.

Figure 3. Model of cathepsin B
dispersion within chGal3 expressing
cells.

EXPERIMENTAL DESIGN
SH-SY5Y neuroblastoma cells expressing mCherry-Galectin 3 were plated onto
Fibronectin coated coverslips at a density of 25,000 cells/ml within a 24-well plate and
allowed to adhere overnight. For plating, cells were initially separated into three groups:
untreated, α-syn treated, and a negative control for cathepsin B which involved secondary
antibody staining only. In later trials, a positive control for vesicle rupture was added as a
fourth sample group, which consisted of 10mM LLOMe treatment. The following day,
conditioned DMEM was aspirated and replaced with either 500ul of fresh DMEM for
nontreated control and LLOMe samples, or 500ul fresh DMEM containing 3ug/mL α-syn
for treated samples and secondary only control samples. After 24 hours of α-syn treatment,
samples were fixed and stained for cathepsin B. Samples were then mounted to slides with
FluoromountTM Aqueous Mounting Medium (Sigma-Aldrich), imaged using fluorescence
deconvolution microscopy, and analyzed for prevalence of cathepsin B puncta. A
secondary only control was included to confirm specificity of primary antibodies.
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To determine the legitimacy of cathepsin B staining, a simultaneous IF stain for
mouse anti-EEA1 and mouse anti-LAMP-2, labeled with subsequent incubation with 488conjugated anti-mouse secondary antibody, was performed in conjunction with cathepsin
B staining to confirm cathepsin B localization to all relevant vesicular compartments.
RESULTS
Early experiments in this series showed promising results in favor of α-syn
induced cathepsin B dispersion. When chGal3 expressing SH-SY5Y cells were treated
with 3ug/ml α-syn aggregates, there was an extremely significant decrease in the number
of detected cathepsin B puncta compared to untreated controls in select trials (Figure #4i & iv). Replicate experiments were carried out in the pursuit of additional evidence to
strengthen our conclusions, and to overcome initial issues with chGal3 signal loss during
IF staining. In later trials, the duration of the cell fixation protocol was increased from 5
to 20 minutes, which gave rise to successful retention of chGal3 rupture signal through IF
staining (Figure #4-ii). However, later trials failed to produce significant dispersion of
cathepsin B staining, even after multiple replicates were conducted. In an attempt to
achieve unequivocal cathepsin B dispersion, cells were treated with LLOMe at a
generous 10 mM concentration. These positive control samples displayed clear and
extensive rupture (Figure #4-iii), yet failed to produce differences in the prevalence of
cathepsin B puncta per cell compared to untreated samples, even after several trials
(Figure #4-v). Due to our interest in cytososolic cathepsin B dispersion as an effector of
cell viability, we decided to alter our analysis to exclude irrelevant nuclear and
extracellular cathepsin B signal through the use of image masking in the Imaris software
package (Bitplane) with the hope that it may unveil a larger margin of difference in
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cytosolic cathepsin B puncta between treated and untreated samples (Figure #5).
Although image masking did appear to have this effect to some extent, even these trials
failed to achieve significance (Figure #4-vi). In a final attempt to determine the fault in
our experimental design, cells were simultaneously stained for EEA1 and LAMP2 in the
488nm emission channel, in addition to cathepsin B in the 576nm emission channel, at
which point it became clear that our cathepsin B stain with different antibodies was not
colocalizing with known markers of protease containing vesicles, and therefore must be
producing a non-specific signal (Figure #6).
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Figure 4. Cathepsin B Dispersion Results (i) chGal3 SH-SY5Y cells (a) Untreated for 24 hours, fixed, and IF stained
for Cathepsin B. (c) Treated with 3ug/ml of α-syn for 24 hours, fixed and IF stained for Cathepsin B. (e) Repeat of
(c) without primary antibody staining. Primary staining done with 0.5ug/ml of polyclonal rabbit anti-cathepsin B
(Santa Cruz), and secondary staining with 1:500 dog anti-rabbit 676. Panels (b), (d), and (f) are duplicate images of
the preceding column with only Cathepsin B displayed. (ii) Successful retention of chGal3 puncta, displaying
rupture induced by α-syn in independent channels for chGal3 (a), α-syn (b), cathepsin B (c), and merged (d). (iii)
LLOMe treated samples induce lysosomal rupture apparent by chGal3 puncta formation. (iv) Quantification of
Cathepsin B surfaces between treatment groups for a single trial (15 images per group). (v) Common results which
failed to achieve significance, even with 10 mM LLOMe treatment. (vi) Post masking results from panel (v)
demonstrate improved significance by masking in select instances. Images are pseudo-colored for optimal
visualization of specific effects.
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Figure 5. Demonstration of the cell masking process for exclusion of nuclear and extracellular
cathepsin B puncta. Panel A represents raw images before masking. Nuclear puncta were
excluded by setting cathepsin B staining within DAPI masks to a fluorescence level of zero (B).
Extracellular cathepsin B staining was excluded by setting puncta outside of chGal3 whole-cell
masks equal to zero (C). Post masking images (D) were then analyzed for total cytosolic
cathepsin B puncta using the high-throughput Batch tool of Imaris (Bitplane).
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Figure 6. Confirmation of non-specific anti-cathepsin B binding. Wild type SH-SY5Y cells were
plated onto Fibronectin coated coverslips 24 hours prior to fixation. Cells were then IF stained
with one of two polyclonal, rabbit anti-Cathepsin B antibodies (Abcam at 1ug/ml in panels (a), (b)
and (c), or Santa Cruz at 0.5ug/ml in panels (d), (e) and (f)). All vesicles that should contain either
pro-cathepsin B or mature cathepsin-B, including early endosomes, primary lysosomes, and
secondary lysosomes (endocytic and autophagic), have been immunofluorescently labeled by
simultaneous IF staining with mouse anti-EEA1 and mouse anti-LAMP2 primary antibodies
followed by anti-mouse 488 secondary staining. Images were then analyzed for colocalization.
Images in each row are the same field. The far left column displays Cathepsin B and DAPI. The
central column displays EEA1/LAMP2 and DAPI. The far right column displays merged images.
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DISCUSSION
Due to the confirmed intraluminal localization of cathepsin B to acidified vesicles
under normal conditions, cathepsin B signal from IF staining should parallel that of the live
cell Lysotracker dye which serves as a marker of acidic compartments86,87. Contrary to our
expectations, however, the resulting puncta from IF staining of cathepsin B was far more
abundant, had a much smaller than expected size distribution, and was present both
extracellularly and within the nuclei of stained neuronal cells. Additionally, the results
from the preliminary experiments of this study indicated a strikingly significant decrease
in cathepsin B puncta with treatment of α-syn aggregates, despite there being essentially
no measurable rupture events (chGal3 puncta) to explain the cathepsin B dispersion
(Figure #4-i). Although secondary only controls were successful (Figure #4-i), these
uncharacteristic staining patterns prompted further investigation into the binding
specificity of the anti cathepsin B primary antibodies. Several trials of the experiment were
repeated adjusting cell fix duration, antibody incubation time, α-synuclein species, and data
analysis (masking), yet repeat experiments continuously failed to achieve significance. In
later trials, chGal3 puncta was successfully retained through the IF protocol, most likely
due to an increase in cell fixation from 5 to 20 minutes, however, overall results of
cathepsin B dispersion as a result of α-syn treatment never achieved significance in
triplicate.
As a positive control for the lysosomal rupture that α-syn aggregates are capable of
inducing, samples were treated with the peptide drug LLOMe. Initially, samples were
treated with 1mM LLOMe based on previously published work45, but treatment
concentration was eventually adjusted to 10mM after titration experiments were conducted
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to elicit an appropriate effect in our specific cell line. Even the drastically high levels of
rupture measured in the LLOMe treated samples resulted in no measurable difference in
cathepsin B puncta, indicating no form of dispersion. At this point in the study, the only
factor left invalidated was the primary anti-cathepsin B antibodies, which became highly
suspect for nonspecific binding. To determine conclusively whether the cathepsin B
staining in this study was legitimate, a simultaneous IF stain for mouse EEA1, LAMP-2,
and cathepsin B was performed. This control served as final confirmation that the IF signal
of each of the anti-cathepsin B antibodies used was entirely non-specific and did not
colocalize with the previously characterized EEA1 or LAMP2 antibody stains as expected.
These results confirmed that the preliminary measured effect cannot be explained by
treatment with α-syn, making this aim of our study inconclusive. Due to the certain
detrimental effects that cathepsin B dispersion could cause within neuronal populations
(Figure #7), future experiments will be conducted to accurately investigate the effect of αsyn treatment on lysosomal protease localization.
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Figure 7. Full model of cathepsin B dependent cell death as a down-stream effect of α-syn induced
rupture.

`
CHAPTER FIVE
POST-RUPTURE LYSOSOMAL FUNCTION
INTRODUCTION
Understanding the fate of lysosomes after α-syn-induced rupture will be critical to
understanding intracellular trafficking and propagation of α-syn in synucleinopathies. If
we can identify the prevalence of various post-rupture lysosomal populations, we can begin
to confirm details of α-syn toxicity and form more accurate hypotheses about the
mechanistic details of pathogenic α-syn aggregation and propagation. The primary purpose
of this study was to determine if lysosomes are completely destroyed by rupture events. If
lysosomes are completely and permanently ruptured by α-syn aggregates, this would result
in a complete loss of functional degradation, release of lysosomal contents, and subsequent
contribution of exogenous α-syn to the formation of cytosolic inclusions. Each of these
events can contribute to increased strain on remaining cellular degradative pathways over
time, and can directly promote cell death through activation of previously mentioned
necrotic or apoptotic pathways. Alternatively, lysosomes may be minimally permeabilized
in some cases, causing functional loss due to proton leakage without complete release of
contained α-syn aggregates. If this is the case, these non-functional lysosomes containing
α-syn may become targets for macroautophagy, resulting in their engulfment to form
MVB-like structures and subsequent, non-classical release of α-syn by fusion with the
plasma membrane to secrete exosome-like vesicles of lysosomal origin. Conversely,
perhaps a significant number of lysosomes are able to reseal following α-syn induced
rupture, thereby regaining function and maintaining involvement in both degradation of
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accumulating α-syn aggregates. We hypothesized that the majority of lysosomes would
rupture to the extent that they permanently lose degradative capacity, indicated by low
prevalence of lysosomes (Lysotracker positive) that are also positive for the chGal3 rupture
marker.
EXPERIMENTAL DESIGN
The same SH-SY5Y chGal3 cells were plated in 1 mL of DMEM at a density of
50,000 cells/ml onto Fibronectin coated live-cell Delta T dishes and allowed to adhere
overnight. The following day, the conditioned media was replaced with 1 mL of fresh
DMEM containing 3 ug/ml of aggregated and labeled α-syn. In control dishes, the same
media changes were performed using media lacking α-syn. After 24 hours of treatment
with α-syn aggregates, dishes washed with fresh DMEM and sequentially treated with
25nM Lysotracker dye in colorless DMEM for 20 minutes, followed by final replacement
of media with standard colorless DMEM immediately before imaging. Images were then
collected using wide field deconvolution microscopy, and analyzed for colocalization on
the Imaris software package by Bitplane. Control samples undergoing parallel media
changes, but lacking α-syn treatment, were used to validate the chGal3 rupture system in
this context.
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Colocalization Analysis

Α-syn
chGal3
Lysotracker

Figure 8. Three dimensional fluorescent images of the colocalization analysis
process in SH-SY5Y cells. The far left image is a composite of all three channels.
Middle column displays the indicated, individual channels. The far right column
displays surface algorithm applied to detect puncta characteristics in each
independent channel.

RESULTS

Figure 9. The effect of α-syn treatment on chGal3 labeled rupture events.
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(i)

(iii)

(ii)

Figure 10. Triple colocalization data
graphed by maximum fluorescent
intensity of chGal3, Lysotracker, and/or
α-syn signals for (i) Lysotracker surfaces
(ii) α-syn surfaces and (iii) chGal3
surfaces.
Threshold
lines
were
determined by visual determination of
fluorescent signal above adjacent
background. Correlation analysis was
conducted and revealed a significant
relationship between Alpha synuclein
intensity and Galectin 3 intensity in
Lysotracker surfaces (ii), indicating a
potential for brighter, larger aggregates
to better induce rupture.

The results of this experiment expand our current understanding of vesicle rupture
by revealing various existing vesicle populations as exogenous α-syn is processed by the
cell. The colocalization data above are displayed much like data acquired by FACS,
although data points represent individual vesicles rather than cells (Figure #10).
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Alpha synuclein surfaces (Figure #11) represent all surfaces built around α-syn
puncta. Of these surfaces, the largest portion are positive only for α-syn (mean = 54.3%).
This population may represent α-syn bound to the extracellular surface, contained within
early endosomes that have yet to acidify, or α-syn that has ruptured and escaped vesicles
to exist independently in the cytosol. Conversely, the smallest population of α-syn surfaces
were double positive for α-syn and chGal3 (α-syn+/chGal3+). This type of colocalization
between chGal3 and α-syn is most likely to occur through a mutual interaction with the
vesicle membrane, meaning that the α-syn+/chGal3+ population represents ruptured
vesicles that have remained bound to α-syn (mean = 8.6%)46,50. Surfaces built around αsyn puncta that were positive for Lysotracker were fairly prevalent as well (15.7%),
supporting previous findings that α-syn aggregates are taken up through the endocytic
pathway where their host endosome can fuse with primary lysosomes79. Most notably, the
presence of triple positive population of α-syn surfaces (21.2%) suggests that ruptured αsyn+/chGal3+ vesicles are likely to be sequestered within acidified compartments through
unconfirmed mechanisms.

Figure 11. Triplicate means of colocalization populations
within α-syn surfaces.
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Lysotracker surfaces (Figure #12), on the other hand, represent all intact, low pH
organelles, which may include a small population of late endosomes and autophagosomes,
but mainly encompasses primary and secondary lysosomes (ThermoFisher). Surprisingly,
the most prevalent population of Lysotracker surfaces were triple positive (44.1%), in
contradiction to our predictions that this population would not exist. Similar to the
populations from other surfaces, the two double positive populations were the least
abundant. The population of Lysotracker and α-syn positive surfaces is measured a second
time here in the context of Lysotracker surfaces rather than α-syn surfaces, and again,
represents pre-rupture endocytic lysosomes containing α-syn aggregates (19.8%). Vesicles
double positive for Lysotracker and chGal3 may represent various events. Maybe they arise
as a result of autophagic uptake of chGal3 positive debris from previous lysosomal rupture.
Perhaps these Lysotracker and chGal3 positive vesicles occur due to lysosomal reseal after
rupture, followed by successful degradation of the offending α-syn aggregate. However,
this population is the least abundant (6.92%), and is therefore less likely to be a main
outcome in α-syn intracellular trafficking. More certainly, Lysotracker only surfaces
(29.1%) are likely to represent the pool of primary lysosomes prior to formation of
secondary lysosomes through fusion with either endosomes or autophagosomes.
Interestingly, the population distribution of lysosomes from the pool of Lysotracker only
vesicles appears to vary inversely with the population of triple positive lysosomes between
trials (Figure #12).
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Figure 12. Triplicate means of colocalization populations
within Lysotracker surfaces.

Galectin 3 surfaces (Figure #13) mainly represent lysosomal rupture events, and
a small portion of early endosomal rupture based on previous results7. Of the cumulative
6,190 rupture events measured between trials (galectin 3 surfaces), a surprising average of
73.6% of rupture events were also positive for Lysotracker and α-syn. An average of
20.05% of rupture events were negative for Lysotracker, indicating that a significant
population of lysosomes at this time point experience rupture which disrupts the low pH
environment of the lysosome and causes dispersion of the Lysotracker dye. In line with
common observation from previous surface analysis, the population of Lysotracker/chGal3
positive vesicles are the least abundant (6.36%). Galectin-3 puncta also underwent
additional investigation to determine prevalence between untreated and α-syn treated
samples. It is worth noting that the chGal3 assay system is not perfect, and does produce
background signal from spontaneous rupture to a small extent in untreated samples.
However, the results from this analysis demonstrate a substantial increase in chGal3
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labeled rupture induced by α-syn treatment, demonstrating the validity of the assay (Figure
#9).

Figure 13. Triplicate means of colocalization populations
within chGal3 surfaces.

These results most importantly raise questions about the population of triple
positive puncta abundantly present in each of the surface analyses. What do they represent,
and how are they formed? Could triple positive puncta indicate a potential for lysosomes
to reseal after rupture, or are ruptured α-syn+/chGal3+ lysosomes rendered non-functional
and therefore simply targeted for macroautophagy and sequestered back inside of
independent acidified autolysosomes?
In order to more accurately address this key question, volumes of α-syn, chGal3,
and Lysotracker surfaces were analyzed between these different populations. This analysis
was based on the idea that resealed lysosomes would maintain relatively constant volumes
within these two surfaces, while triple positive puncta formed through macroautophagic
uptake of previously ruptured vesicles would likely vary more widely in volume. Volume
analysis reveals fascinating evidence that the triple positive puncta contain far larger
volumes of α-syn aggregates and larger volumes of Lysotracker dye compared to single
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positive puncta of either marker (Figure #14-i & ii). To supplement this data, maximum
intensity between colocalization populations was also analyzed (Figure #14-iii).

(i)

(ii)

(iii)
Figure 14. Volume differences between
four colocalization populations in α-syn
surfaces (i) and Lysotracker surfaces (ii), and
maximum fluorescence intensity differences
between the four colocalization populations
in α-syn surfaces (iii). All graphs include
results from triplicate experiments.
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DISCUSSION
Based on the results of this study and previously published findings, the following
vesicle outcome map has been generated to predict intermediate phases of intracellular αsyn trafficking from uptake to release.

α-syn
chGal3
Lysotracker
Figure 15. Vesicle outcome map depicting potential pathways for the intracellular trafficking of αsyn aggregates in a whole-cell context. Initial endocytosis is depicted on the left side. As α-syn
progresses through the endocytic pathway, the host vesicle acidifies, sequestering acidophilic
Lysotracker dye to become Lysotracker positive. Double positive lysosomes containing α-syn may
then successfully degrade α-syn, or rupture to recruit chGal3. Lysosomal rupture may occur
transiently, allowing lysosomes to reseal (top path), or may result in complete disruption of the
lysosomal membrane and loss of Lysotracker signal (bottom path). Intact, post-rupture lysosomes
may continue to function, or may exist as acidic, Lysotracker positive, yet non-functional vesicles
devoid of necessary proteases, in which case they may undergo lysosomal exocytosis to deposit
accumulated contents (top). If lysosomes are fully ruptured, however, they may become targets for
macroautophagy to end up as triple positive species to undergo continued degradation of
accumulating α-syn, or simply undergo lysosomal exocytosis to release apparent ‘exosome-like’
structures from the cell (far right). Lysosomal exocytosis is a calcium dependent process.
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The path of exogenous α-syn aggregates as they are processed by the cell has
become considerably more clear based on the results of this study. Initially, α-syn
aggregates can be seen as independently fluorescent puncta near PM, likely contained
within early endosomes (Figure). This early-entry population of α-syn is likely to account
for a large majority of ‘α-syn only’ positive surfaces (Figure #11). The exact
mechanisms of uptake remain to be elucidated, but our detection of double positive α-syn
and Lysotracker vesicles serves as substantial evidence, in agreement with previous
findings, that α-syn is taken up through the endocytic pathway to be contained within
endocytic lysosomes79.
Once the α-syn aggregates are internalized, the mechanism in which they gain
access to the cytosol has been widely debated4. Although our data does not specifically
highlight temporal aspects of intracellular α-syn trafficking, it does strongly corroborate
our previous findings and hypothesis that vesicle rupture is the mechanism of cytosolic
entry for exogenous α-syn aggregates7. If rupture does occur later in the endocytic
pathway at the stage of endocytic lysosomes, as per our previous findings7, then it can be
said that the chGal3 surfaces predominantly represent ruptured lysosomes. Under this
assumption, our chGal3 data indicates that at least 20.05% of rupture events induced by
α-syn cause dissipation of Lysotracker signal, indicating severe disruption of the
lysosomal membrane leading to the dissipation of luminal contents. In each of these
cases, α-syn is likely to be exposed in the cytosol with the potential to interact with other
exogenous aggregates and act as a template for misfolding of endogenous α-syn,
ultimately explaining the ability of exogenous aggregates to contribute to the
development of toxic LB and LN structures3,65,66. Furthermore, the subset of rupture
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events that are positive for chGal3 alone (6.05%) represent potential for complete release
of free α-syn aggregates from ruptured vesicles into the cytosol to induce the same,
unhindered nucleation effect.
In fact, it is possible that a much larger population of rupture events causes
complete destruction of lysosomes, depending on the origin of triple positive puncta.
There are two possible outcomes for ruptured lysosomes that could give rise to the triple
positive vesicles observed in this study. First, lysosomes may remain independently
functional after transient permeabilization, retention of α-syn aggregates, and recruitment
of chGal3. However, if this were the case, the overall volume of triple positive vesicles
would be likely remain constant, making primary lysosomes (Lysotracker only) the same
size as triple positive vesicles. Based on our volume analysis of both α-syn and
Lysotracker surfaces, we can confidently say that this is not always the case. A
significant population of triple positive puncta contain much larger volumes of α-syn
aggregates than α-syn aggregates in pre-ruptured lysosomes (means = 1.261 µm3 vs
0.3092 µm3, respectively), with higher fluorescence intensities (Figure #14-i & iii).
Additional analysis of Lysotracker surface volumes reveals the same pattern of increased
volume for triple positive puncta compared to Lysotracker only, primary lysosomes
(means = 1.045 µm3 vs 0.5028 µm3) (Figure #14-ii), reflecting the known volume
differences between primary lysosomes and autolysosomes (lysosome volume range: up
to 0.065 µm3, autolysosome volume range: up to several µm3 )88,89. These results strongly
suggest that triple positive vesicles can be formed by cumulative recruitment of ruptured
α-syn+/chGal3+ lysosomes to distinct intact lysosomes, which, through known
mechanisms, could only be explained by macroautophagy. Uptake of these ruptured
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lysosomes is also likely to be occurring at a rate which exceeds the degradative capacity
of the autolysosomes, especially under these conditions of lysosomal dysfunction. This
indicates that a significant portion of the triple positive puncta also include previous, fully
ruptured lysosomes, meaning that the frequency of complete lysosomal destruction by αsyn is certainly larger than the mentioned 20.05%. Of course, this large scale occurrence
of lysosomal destruction would have extremely detrimental effects on neuronal
populations in vivo.
In support of our findings, the Yoshimori lab at the University of Osaka recently
demonstrated the concept that damaged lysosomes can become targets for autophagy45.
Evidence from their study suggests that lysosomal rupture induces upregulation in
autophagy, allowing the clearance of ruptured lysosomes. However, in cells deficient of
essential autophagic proteins, clearance of these ruptured lysosomes was fully
attenuated45. These findings, in congruence with our own, lead us to the conclusion that
the majority of ruptured lysosomes are not simply resealing after rupture, but instead are
being taken up, and accumulating within distinct lysosomal compartments through
macroautophagic mechanisms.

CHAPTER SIX
CALCIUM-DEPENDENT RELEASE OF α-SYNUCLEIN
INTRODUCTION
Thus far, this study has shed light on mechanisms of uptake and intracellular
processing of exogenous α-syn aggregates, but has yet to address the mechanisms behind
well documented α-syn release and intercellular propagation. If exogenous α-syn
aggregates do progress through the cell, inducing lysosomal rupture, and eventually
becoming secondarily sequestered within autolysosomes, then how can previous findings
of α-syn release from cells be explained?
It has been determined that α-syn aggregates can be released from cells in a calcium
dependent manner in apparent vesicular fractions that have been referred to as exosomes81.
Beyond this, compelling evidence from multiple studies suggests that lysosomal exocytosis
occurs in response to calcium influx, especially in response to the membrane damage73,76.
We hypothesize that under conditions of drastic ALP dysfunction, as is the case during
accumulation of aberrant α-syn, lysosomes will be unable to properly degrade α-syn
aggregates, and will therefore accumulate α-syn aggregates that may be released to the
extracellular space through mechanisms of calcium-induced lysosomal exocytosis.
Understanding whether known mechanisms of lysosomal exocytosis contribute to the
propagation of toxic forms of α-syn could reveal important drug targets for therapeutic
intervention. If lysosomal exocytosis is a predominant form of α-syn propagation, selective
inhibition of this process in cells containing aberrant forms of α-syn aggregates may
become an avenue of further investigation.
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EXPERIMENTAL DESIGN
ChGal3 expressing SH-SY5Y cells were plated onto Fibronectin coated
borosilicate chamber slides and allowed to adhere overnight. To image lysosomes in this
context, cells were treated with 200ul of 1 uM LysoSensor™ Green DND-189
(ThermoFisher) in DMEM for 30 minutes prior to imaging. As per product protocol, cells
remained cultured in LysoSensor™ containing media during imaging. For visualization of
α-syn release, DMEM containing 3ug/ml of DyLight™ 488 labeled α-syn aggregates was
then added to each well of the chamber slides for 24 hour treatment period. After α-syn
treatment, media will be replaced with 200ul of fresh DMEM in each well, and cells will
be imaged by TIRF microscopy. During imaging, calcium ionophores (Ionomycin or Ca2+
Ionophore A23187) will be added within 200ul of DMEM to initiate calcium influx.
Cellular response to calcium influx will be measured by appearance of labeled α-syn,
lysosomes, and galectin3 puncta to the basal plasma membrane. Fluorescence intensity
over time will then be evaluated to identify fusion events of either individual lysosomes or
MVBs.
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RESULTS
For this preliminary study, TIRF microscopy was only achieved within the 488nm
fluorescence emission channel due to limitations of available live cell lysosomal dyes and
compatible fluorescence microscopy filters. For this reason, rather than looking at α-syn
aggregates and lysosomal markers simultaneously, we attempted to first confirm our ability
to induce calcium-dependent lysosomal exocytosis as seen in Simon et al73. Rather than
expressing fluorophore conjugated lysosomal antigens, we attempted to label lysosomes
using the only available live cell lysosomal marker available in the channel in which we
could appropriately image using TIRF, LysoSensor™ Green DND-189 (ThermoFisher).
The LysoSensor stain was fairly successful for visualization of endogenous acidified
compartments by epifluorescence (Figure #17), but unfortunately produced significant
staining of the plasma membrane that prevented proper visualization of lysosomal
compartments while imaging by TIRF (Figure #18).

Figure 16. LysoSensor Staining visualized by
epifluorescent excitation. Acidified vesicles
can be distinguished

Figure 17. LysoSensor Staining visualized by
TIRF excitation. Acidified vesicles cannot be
distinguished through basal membrane
staining.
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Despite this limitation of the LysoSensorTM stain, the possibility of direct
visualization of calcium dependent α-syn release was still of key interest to us, especially
as preliminary evidence to justify further study in this vein. During initial imaging of
DyLight™ 488-labeled α-syn aggregates, a drastic increase in fluorescence intensity was
measured at numerous points within the imaged field immediately following induced
calcium influx (Figure #19). This may indicate calcium dependent migration of vesicular
α-syn aggregates, likely contained within lysosomes and/or autolysosomes, to the plasma
membrane. In some specific regions of interest, patterns of fluorescence dissipation that
would be expected to occur during vesicular fusion events were measured (Figure #20).

a

b

c

d

Figure 18. Demonstration of calcium-dependent α-syn release.
Total internal reflection fluorescence image of chGal3 SH-SY5Y cells
treated with α-syn aggregates for 24 hours at (a) time zero, before
addition of calcium ionophore and (b) time 30 sec, after addition of
calcium ionophore. Images in panels a and b are excited by 488
channel laser only. (c) Image of chGal3 localization with red laser
excitation only. (d) Graph of mean fluorescence intensity over time
for the color coated regions indicated by boxes in panels a and b.
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However, some puncta are much larger, brighter, and appear to remain more highly
fluorescent over time, as indicated in Figure #19 by the green box and corresponding
fluorescence intensity graph. We suspect that this type of change in fluorescence over time
is indicative of a MVB-like structure, likely an autolysosome containing α-syn and debris
from previously ruptured vesicles, fusing with the PM to release both soluble and vesicular
fractions. The majority of α-syn puncta that migrate to the PM in response to calcium influx
appear to do so transiently. An example of this is depicted by the blue box and
corresponding fluorescence intensity graph in Figure #19, where the punctate α-syn
approaches the membrane and quickly returns to baseline intensity. This could indicate
fusion of individual lysosomes to the PM, allowing release of primarily soluble contents
into the extracellular space, resulting in a decrease of fluorescence intensity back to
baseline.

a

b

c

d

e

f

g

Figure 19. Potential release of α-syn by lysosomal exocytosis. (a) Full imaging field taken by TIRF-M.
Multiple SH-SY5Y cells can be seen containing 488-labeled α-syn aggregates. (b-g) Enlarged region of
interest from panel (a) displaying a potential fusion event in 1 second intervals after calcium influx.
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DISCUSSION
Although the results of this preliminary study parallel those of lysosomal
exocytosis in Simon et al73, our findings were less profound. Based on the abundant
localization of α-syn aggregates to lysosomal compartments demonstrated in this study
and previously published studies79, in conjunction with the abundant lysosomal
exocytosis reported in Simon et al, we expected to visualize substantial release of α-syn
aggregates in response to induced calcium influx. However, apparent fusion events were
exceedingly rare. Our results raise questions about the factors that may influence cellular
capacity for lysosomal exocytosis between different cell types.
Factors that may influence lysosomal exocytosis
It has been strongly established that vesicles equipped with SNARE complex
proteins that are capable of calcium-dependent exocytosis exist in distinct pools localized
to different cellular regions. So called ‘fast’ phase exocytosis occurs through the fusion of
of vesicles proximal to inner leaflet of the plasma membrane that are docked and primed
for fusion, awaiting calcium influx for final initiation of exocytosis90. More recently it has
been demonstrated that lysosomes localize to distinct cellular regions much like secretory
vesicles, with membrane proximal lysosomes being most capable of fast phase calciumdependent exocytosis73,91. However, vesicles destined for exocytosis must first be recruited
to the membrane from intracellular pools, the driving force for which is kinesin and myosin
motor activity along microtubules and actin respectively90. However, efficient trafficking
of lysosomes to the membrane for exocytosis is dependent on multiple factors, including
cortical actin, calcium channel expression, cholesterol, and clatherin adaptor proteins
essential for SNARE protein targeting78. These factors influencing lysosomal exocytosis
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are likely to vary in function and prevalence between cell types, making it feasible that
studies exhibiting efficient calcium dependent exocytosis in various non-neuronal cell
types may not translate directly to the neuronal cell lines used in this study. Perhaps the
use of primary dopaminergic neurons from the SNpc, which express specific Cav1.3
calcium channels known for their higher calcium conductance during hyperpolarization,
would better exhibit lysosomal exocytosis and measurable release of α-syn aggregates92.
Furthermore, studies like ours that involve α-syn aggregate treatment add an additional
layer of complexity. This is partially due to the ability of α-syn to alter the structural
dynamics of actin, potentially inhibiting standard vesicular trafficking, and possibly even
stabilizing cortical actin to physically hinder lysosomal access to the plasma membrane93.
Ultimately, it is clear that our experimental approach to this mechanistic study of α-syn
release will need to be refined substantially before accurate conclusions can be drawn.

CHAPTER SEVEN
CONCLUSIONS AND FUTURE DIRECTIONS
Although aspects of our study failed to produce conclusive evidence, there are
multiple components of the colocalization analysis in aim 2 that justify novel and
interesting conclusions with respect to the intracellular trafficking of exogenous α-syn
aggregates. First, this study builds on the largely debated previous evidence in favor of αsyn rupture as the mechanism of exogenous α-syn entry into the cytosol. Additionally, this
study provides the first evidence suggesting that exogenous α-syn aggregates eventually
accumulate within autolysosomes, along with overexpressed chGal3, after inducing
rupture of endocytic vesicles. This conclusion is strongly supported by results of abundant
and drastically enlarged triple positive puncta in our colocalization study, indicative of
acidified vesicles containing cumulatively recruited α-syn+/chGal3+ ruptured vesicles that
may only be explained by mechanisms of macroautophagy. Moreover, accumulation
within autolysosomes suggests that these degradative compartments are incapable of
clearing accumulating α-syn. This could be a result of excessive treatment with α-syn
aggregates, but is also likely to reflect ALP dysfunction. If α-syn is truly accumulating
within autolysosomes as a result of dysfunction, then lysosomal exocytosis remains a key
mechanism of α-syn release as a last line of defense by the cell.
Despite the lack of direct evidence of cathepsin B dispersion in this study, our
model of cathepsin B dependent cell death after α-syn induced vesicle rupture is
strengthened by this study. Based on our colocalization results, we can speculate that
lysosomal disruption is occurring to the extent that substantial cathepsin release is
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occurring, resulting in unregulated necrosis55. Perhaps in cases of PD, especially in early
pathology, cells experience occasional, full rupture of lysosomes, causing release of
cathepsin B and D to cause mild disruption of surrounding structures, mitochondrial
permeabilization, and subsequent release of both Cyt-C and ROS. In later stages of PD
when pathological forms of α-syn are more abundant, however, cell death may occur more
rapidly through mechanisms of necrosis as a result of increased cathepsin release consistent
with our results of drastic lysosomal rupture. Particularly in synucleinopathies with much
faster disease progression and vastly more abundant synuclein inclusions, like DLB,
perhaps unregulated necrosis of neural tissue is the predominant form of cell death as active
cathepsins degrade essential proteins and cause widespread disturbances throughout the
cell. In the future, confirmation of cathepsin B and D dispersion upon α-syn aggregate
treatment will play an important role in confirming or disproving our hypothesis of α-syn
toxicity.
FUTURE DIRECTIONS
In addition to pursuing conclusive results for our unresolved aims, many studies
in the field of PD research have sparked our interest in beginning more expansive studies.
To start, the Jankovic lab at the Baylor College of Medicine has published interesting and
relevant results of autophagic function in the presence of mutant forms of α-syn
aggregates. Their results suggest that some mutant forms of α-syn can strongly bind the
lysosomal membrane antigen, lamp2a, to prevent fusion of autophagosomes to
lysosomes, thereby inhibiting macroautophagy94. We believe this effect may be exclusive
to particular mutant forms of α-syn, in which case, our results suggesting successful
autolysosome formation in the presence of WT α-syn aggregates still stand, although
functional degradation may be inhibited due to saturation of the ALP pathway and
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resulting strain on degradative machinery. Future studies investigating the ability of WT
α-syn aggregates to bind lamp2a, however, may be warranted to verify our findings.
We also plan to further investigate cell response to α-syn treatment from the
perspective of lysosomal synthesis. Evidence from the Björklund lab at Lund University
suggests the lysosomal synthesis regulator, TFEB, is capable of enhancing autophagy
when overexpressed to reduce pathological features of PD in rat models and ex-vivo
human PD midbrains. The reverse effect was seen in TFEB deficient samples, in which
neurotoxicity was increased. We would like to build upon these finding by investigating
the effect of TFEB overexpression on α-syn intracellular trafficking, release, and chGal3
labeled rupture.
Eventually, we also hope to expand upon the chGal3 rupture assay by investigating
the potential role of Galectin-3 in cellular recognition of, and response to, α-syn induced
vesicle rupture. It has been determined that Galectin-3 plays a major role in inflammation
and immunity95. Observations of Galectin-3 release from cells, and co-involvement in αsyn induced microglia activation have also been reported96. For these reasons, we suspect
that there is likely an evolutionary reason for endogenous Galectin-3 to possess a Cterminal carbohydrate recognition domain capable of inducing relocalization of Galectin3 to sites of vesicle rupture. Perhaps Galectin-3 is essential for the activation of the
numerous neuroinflammatory changes that are activated in PD to induce toxicity97. We are
anxious to conduct studies in the future investigating Galectin-3 as a component of LB and
LN structures, contributor to α-syn toxicity, and even effector of α-syn release.
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